TGF-beta-induced nuclear localization of Smad2 and Smad3 in Smad4 null cancer cell lines

Stephen P Fink1, Debra Mikkola, James K V Willson

  • 1Howard Hughes Medical Institute, Cleveland, OH 44106, USA.

Oncogene
|March 6, 2003
PubMed

Insights

Smad4 is not required for Smad2 and Smad3 nuclear translocation in cancer cells. However, Smad4 is essential for activating transforming growth factor-beta (TGF-beta) signaling and transcriptional responses.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Smad4 is a critical tumor suppressor gene frequently altered in colorectal and pancreatic cancers.
  • Transforming growth factor-beta (TGF-beta) signaling, mediated by Smad proteins, is crucial in cellular processes and often dysregulated in cancer.
  • Smad4 loss or mutation has been historically considered sufficient to abolish TGF-beta signaling.

Purpose of the Study:

  • To investigate the role of Smad4 in the nuclear translocation of Smad2 and Smad3 upon TGF-beta stimulation.
  • To determine if Smad4 is necessary for TGF-beta-induced transcriptional responses in Smad4-null cancer cell lines.

Main Methods:

  • Utilized immunofluorescence to track the cellular localization of endogenous Smad2 and Smad3 in multiple Smad4-null cancer cell lines (colon, breast, pancreatic) after TGF-beta treatment.
  • Assessed TGF-beta-induced transcriptional responses using reporter assays.
  • Restored TGF-beta signaling by transfecting wild-type Smad4 into Smad4-null cells.

Main Results:

  • TGF-beta treatment induced nuclear translocation of both Smad2 and Smad3 in all tested Smad4-null cell lines, demonstrating a Smad4-independent process.
  • Nuclear localization of Smad2 and Smad3 alone was insufficient to activate TGF-beta-responsive reporter genes.
  • Transient expression of wild-type Smad4 restored TGF-beta-induced transcriptional activity in these cells.

Conclusions:

  • Smad4 is not essential for the nuclear import of Smad2 and Smad3 in response to TGF-beta.
  • Smad4 plays a critical role in mediating TGF-beta-induced transcriptional activation, downstream of Smad2/Smad3 nuclear translocation.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...